The dilemma of treatments for epileptic patients with depression

References

• National Institute for Health and Clinical Excellence. “Chapter 1: Introduction”. The Epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. National Clinical Guideline Centre. 2012;137:21–28.
   Google Scholar
• National Institute for Health and Clinical Excellence. “Chapter 3: Key priorities for implementation”. The Epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. National Clinical Guideline Centre. 2012;137:55–56.
   Google Scholar
• EadieMJ,. Shortcomings in the current treatment of epilepsy. Expert Review of Neurotherapeutics. 2012;12:1419–1427.
   PubMed Web of Science ®Google Scholar
• Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000;41:s31–s41.
   PubMed Web of Science ®Google Scholar
• Jones JE, Hermann BP, Barry JJ, et al. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003;4:31–38.
   PubMed Web of Science ®Google Scholar
• Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008;13:s1–s29.
   Web of Science ®Google Scholar
• Kanner AM. Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr 2011;11:90–91.
   PubMed Web of Science ®Google Scholar
• Cotterman-Hart S, Depression in epilepsy: why aren't we treating? Epilepsy Behav 2010;19:419–421.
   PubMed Web of Science ®Google Scholar
• Noe K, Locke D, Sirven J. Treatment of depression in patients with epilepsy. Curr Treat Options Neurol 2011;13:371–379.
   PubMed Web of Science ®Google Scholar
• McPhee SJ, Hammer GD.Pathophysiology of disease: an introduction to clinical medicine. 6th ed. New York: McGraw-Hill Medical; 2010, ISBN 978-0-07-162167-0.
   Google Scholar
• McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 2001;63:815–846.
   PubMed Web of Science ®Google Scholar
• Bialer M. Chemical properties of antiepileptic drugs (AEDs). Adv Drug Deliv Rev 2012;64:887–895.
   PubMed Web of Science ®Google Scholar
• Larson W, Dudra-Jastrzebska M, Rejdak K, Czuczwar SJ. Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacol Rep 2011;63:271–292.
   PubMed Web of Science ®Google Scholar
• Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics 2007;4:18–61.
   PubMed Web of Science ®Google Scholar
• Brickley SG, Mody I. Extrasynaptic GABAA receptors: their function in the CNS and implications for disease. Neuron 2012;73:23–34.
   PubMed Web of Science ®Google Scholar
• Luszcki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep 2009;61:197–216.
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553–564.
   PubMed Web of Science ®Google Scholar
• Larson W, Chlebicka M, Rejdak K. Research advances in basic mechanisms of seizures and antiepileptic drug action. Pharmacol Rep 2013;65:787–801.
   PubMed Web of Science ®Google Scholar
• Morland C, Nordengen K, Gundersen V. Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals. Neurosci Lett 2012;527:100–104.
   PubMed Web of Science ®Google Scholar
• Kohling R. Voltage-gated sodium channels in epilepsy. Epilepsia 2002;43:1278–1295.
   PubMed Web of Science ®Google Scholar
• Costord ND, Meinke PT, Stauderman KA, Hess SD. Recentant advances in the modulation of voltage-gated ion channels for the treatment of epilepsy. Curr Drug Targets CNS Neurol Disord 2002;1:81–104.
   PubMedGoogle Scholar
• Martin DJ, McClelland D, Herd MB, et al. Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurons is dependent on culture conditions and channel subunit expression. Neuropharmacology 2002;42:353–366.
   PubMed Web of Science ®Google Scholar
• Amiceli F, Soldovieri MV, Matire M, Tagliabltela M. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol 2008;8:65–74.
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Bazil CW. New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep 2008;8:345–352.
   PubMed Web of Science ®Google Scholar
• Postea O, Biel M. Exploring HCN channels as novel drug targets. Nat Rev Drug Discov 2011;10:903–914.
   PubMed Web of Science ®Google Scholar
• Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologist should know. Epilepsia 2013;54:3–12.
   PubMed Web of Science ®Google Scholar
• Cramer JA, Blum D, Fanning K, Reed M. Epilepsy impact project group: the impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004;5:337–342.
   PubMed Web of Science ®Google Scholar
• Hirschfeld R, Keller M, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the under treatment of depression. JAMA 1997;277:330–341.
   Google Scholar
• Kaczynska-Haladyj M. Depression disorders in children and adolescents with epilepsy: etiology, clinical semiology and treatment. Pharmacol Rep 2007;59:115–124.
   Google Scholar
• Wiegartz P, Seidenberg M, Woodard A, et al. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999. 53(suppl 2):3–8.
   PubMedGoogle Scholar
• Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013;80:590–599.
   PubMed Web of Science ®Google Scholar
• Grabowska-Grzyb A, Jedrzejczak J, Nagańska E, Fiszer U. Risk factors for depression in patients with epilepsy. Epilepsy Behav 2006;8:411–417.
   PubMed Web of Science ®Google Scholar
• Bear DM, Fedio P. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977;34:454–467.
   PubMed Web of Science ®Google Scholar
• Blumer D. Evidence supporting the temporal lobe epilepsy personality syndrome. Neurology 1999;53:9–12.
   PubMedGoogle Scholar
• Kanner AM, Kozak AM, Frey M. The use of sertraling in patients with epilepsy: is it safe? Epilepsy Behav 2000;1:100–105.
   PubMed Web of Science ®Google Scholar
• Wiglusz MS, Cubala WJ, Galuszko-Wegielnik M, et al. Mood disorders in epilepsy-diagnostic and methodological considerations. Psychiatr Danub 2012;24(suppl):44–50.
   PubMedGoogle Scholar
• Pompili M, Girardi P, Ruberto A, et al. Suicide in the epilepsies: a meta-analysis investigation of 29 cohorts. Epilepsy Behav 2005;7:305–310.
   PubMed Web of Science ®Google Scholar
• Bell GS, Gaitatzis A, Bell, CL, et al. Suicide in people with epilepsy: how great is the risk? Epilepsia 2009;50:1933–1942.
   PubMed Web of Science ®Google Scholar
• Mula M, Schmitz B. Depression in epilepsy: mechanisms and therapeutic approach. Ther Adv Neurol Disord 2009;2:337–344.
   PubMedGoogle Scholar
• Victoroff JI, Benson DF, Engel J Jr, et al. Interictal depression in patients with medically intractable complex partial seizures: electroencephalography and cerebral metabolic correlates [abstract]. Ann Neurol 1990;28:221.
   Web of Science ®Google Scholar
• Indaco A1, Carrieri PB, Nappi C, et al. Interictal depression in epilepsy. Epilepsy Res 1992;12:45–50.
   PubMed Web of Science ®Google Scholar
• Victoroff JI, Benson DF, Grafton ST, et al. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol 1994;51:155–163.
   PubMed Web of Science ®Google Scholar
• Robertson MM, Channon S, Baker J. Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study. Epilepsia 1994;35:771–777.
   PubMed Web of Science ®Google Scholar
• Blanchet P, Frommer GP. Mood change preceding epilepticserizure. J Nerv Ment Dis 1986;174:471–476.
   PubMed Web of Science ®Google Scholar
• Williams D. The structure of emotions reflected in epileptic experiences. Brain 1956;79:29–67.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Soto A, Kanner-Gross HR. There is more to epilepsy than seizures: a reassessment of the postictal period. Neurology 2000;54(suppl):352A.
   Google Scholar
• Kanner AM, Barry JJ. Is the psychopathology of epilepsy different from that of nonepileptic patients? Epilepsy Behav 2001;2:170–186.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Rabinovich A, Soto A, et al. The prevalence of postictal symptoms of depression in patients treated in teriary epilepsy centers: a transcultureal perspective. Epelepsia 1999;40(suppl):A147.
   Google Scholar
• Blumer D, Montouris G, Davies K. The interictal dysphoric disorder: recognition pathogenesis and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav 2004;5:826–840.
   PubMed Web of Science ®Google Scholar
• Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(suppl 10):S21–47.
   PubMedGoogle Scholar
• Hermann BP, Seidenberg M, Bell M. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000;41(suppl 2):S31–41.
   PubMedGoogle Scholar
• Betts TA. A follow-up study of a cohort of patients with epilepsy admitted to psychiatric care in a English city. In: Harris P, Mawdsley C, eds. Epilepsy proceedings of the Hans Berger Centenary symposium. Edinburgh: Churchill Livingston; 1974;326–338.
   Google Scholar
• Mendez MF, Doss RC, Taylor JL, et al. Depression in epilepsy: relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis 1993;181:444–447.
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older patients. Ann Neurol 2000;47:246–249.
   PubMed Web of Science ®Google Scholar
• Smith PF, Darlington CL. Neural mechanisms of psychiatric disturbances in patients with epilepsy. In: McConnell HW, Snyder PJ, eds. Psychiatric comorbidity in epilepsy. Basic mechanisms, diagnosis, and treatment. Washington, DC: American Psychiatric Press; 1998;15–35.
   Google Scholar
• Trimble M. Non-monoamine oxidase inhibitor antidepressants and epilepsy: a review. Epilepsia 1987;19:241–251.
   Google Scholar
• Kanner AM. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr 2006;6:141–146.
   PubMedGoogle Scholar
• Robertson MM. Forced normalization and the aetiology of depression in epilepsy. In: Trimble MR and Schmitz B (eds), Forced normalization and alternative psychoses of epilepsy, Persfield: Wrightson Biomedical Publishing; 1998;143–167.
   Google Scholar
• Kimbrell TA, Ketter TA, George MS, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 2002;51:237–252.
   PubMed Web of Science ®Google Scholar
• Baxter LR, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243–250.
   PubMed Web of Science ®Google Scholar
• Werhahn KJ, Landvogt C, Klimpe S, et al. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: An 18F Fallypride PET study. Epilepsia 2006;47:1392–1396.
   PubMed Web of Science ®Google Scholar
• Rocha L, Alonso-Vanegas M, Villeda-Hernandez J, et al. Dopamine abnormalities in the neocortex of patients with temporal lope epilepsy. Neurobiol Dis 2012;45:499–507.
   PubMed Web of Science ®Google Scholar
• Sharopov S, Moser J, Chen RQ, et al. Dopaminergic modulation of low-Mg2+-induced epileptiform activity in the intact hippocampus of the newborn mouse in vitro. J Neurosci Res 2012;90:2020–2033.
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, HJauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006;59:35–41.
   PubMed Web of Science ®Google Scholar
• Taycan SE, Taycan O. Affective temperament profiles and clinical correlates in patients with epilepsy: a link from mood disorders. J Affect Disord 2014;164:1–4.
   PubMed Web of Science ®Google Scholar
• Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 2013;31:761–777.
   PubMed Web of Science ®Google Scholar
• Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006;7:137–151.
   PubMed Web of Science ®Google Scholar
• Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008;33:368–377.
   PubMedGoogle Scholar
• Ruhe HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007;12:331–359.
   PubMed Web of Science ®Google Scholar
• Tanti A, Belzung C. Open questions in current models of antidepressant action. Br J Pharmacol 2010;159:1187–1200.
   PubMed Web of Science ®Google Scholar
• Bonanno G, Giambelli R, Raiteri L, et al. Chronic antidepressants reduce depolarization evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 2005;25:3270–3279.
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009;61:105–123.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008;7:426–437.
   PubMed Web of Science ®Google Scholar
• Curran S, Pauw KD. Selecting an antidepressant for use in a patient with epilepsy: Safety considerations. Drug Saf 1998;18:125–133.
   PubMed Web of Science ®Google Scholar
• Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997;340:249–258.
   PubMed Web of Science ®Google Scholar
• Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated”. Br J Pharmacol 2007;151:737–748.
   PubMed Web of Science ®Google Scholar
• Leistedt SJ, Linkowski P. Brain, networks, depression, and more. Eur Neuropsychopharmacology 2013;23:55–62.
   PubMed Web of Science ®Google Scholar
• Castren E. Is mood chemistry? Nat Rev Neurosci 2005;6:241–246.
   PubMed Web of Science ®Google Scholar
• Buzsaki G. Large-scale recording of neuronal ensembles. Nat Neurosci 2004;7:446–451.
   PubMed Web of Science ®Google Scholar
• Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rate hippocampus. J Neurosci 2000;20:9104–9110.
   PubMed Web of Science ®Google Scholar
• Mula M, Monaco F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord 2009;11:1–9.
   PubMed Web of Science ®Google Scholar
• Schmitz B. The effects of antiepileptic drugs on behavior. In: Trimble M, Schmitz B eds. The neuopsychiatry of epilepsy. 2nd edn. Cambridge: Cambridge University Press; 2011:133–142.
   Google Scholar
• Mula M, Sabder JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30:555–567.
   PubMed Web of Science ®Google Scholar
• Mula M, Hesdorffer DC, Trimble M, Sander JW. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia 2009;50:1072–1076.
   PubMed Web of Science ®Google Scholar
• Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53:S53-S67.
   PubMed Web of Science ®Google Scholar
• Reijs R, Aldenkamp AP, De Kron M. Mood effects of antiepileptic drugs. Epilepsy Behav 2004;Sippul 1:S66-S76.
   Google Scholar
• Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995;34:275–281.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Depression in epilepsy: a neurobiologic perspective. Epilepsy Curr 2005;5:21–27.
   PubMedGoogle Scholar
• Kanner AM, BalabanovA. Depression and epilepsy: how closely related are they? Neurology 2002;58:s27–s39.
   PubMed Web of Science ®Google Scholar
• Busch FN, Sandberg LS. Combined treatment of depression. Psychiatr Clin North Am 2012;35:165–179.
   PubMed Web of Science ®Google Scholar
• Trimble MR, Meldrum BS, Anlezark G. Effect of nomifensine on brain amines and epilepsy in photosensitive baboons. Br J Pharmacol 1977;4(suppl 2):101S–107S.
   Google Scholar
• Lloyd KG, Thuret F, Pilc A. Up-regulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther 1985;235:191–199.
   PubMed Web of Science ®Google Scholar
• Green AR. Changes in gamma aminobutyric acid biochemistry and seizure threshold. Ann N Y Acad Sci 1986;462:105–119.
   PubMed Web of Science ®Google Scholar
• Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999;53(suppl 2):S68–S75.
   PubMedGoogle Scholar
• Dailey JW, Naritoku, DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 1996;52:1323–1329.
   PubMed Web of Science ®Google Scholar
• Richelson E. Pharmacology of antidepressants—characteri-stics of the ideal drug. Mayo Clin Proc 1994;69:1069–1081.
   PubMed Web of Science ®Google Scholar
• Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(suppl 10):S21–S47.
   PubMedGoogle Scholar
• Igelström KM. Preclinical antiepileptic actions of selective serotonin reuptake inhibitors–implications for clinical trial design. Epilepsia 2012;53:596–605
   PubMed Web of Science ®Google Scholar
• Bravo TP, Hoffman-Snyder CR, Wellik KE, et al. The effect of selective serotonin reuptake inhibitors on the frequency of psychogenic nonepileptic seizures: a critically appraised topic. Neurologist 2013;19:30–33.
   PubMed Web of Science ®Google Scholar
• Meador KJ. Seizure reduction with fluoxetine in an adult woman with Dravet syndrome. Epilepsy Behav Case Rep 2014;2:54–56.
   PubMedGoogle Scholar
• Igelstrom KM. Preclinical antiepileptic actions of selective serotonin reuptake inhibitors-implications for clinical design. Epilepsia 2012;53:596–605.
   PubMed Web of Science ®Google Scholar
• Jobe PC, Browning RA. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav 2005;7:602–619.
   PubMed Web of Science ®Google Scholar
• Perry PJ, Alexander B, Liskow BI. Psychotropic drug handbook. 7th ed. Washington, DC: American Psychiatric Press; 1997;453–501.
   Google Scholar
• Ereshefsky L. Drug-drug interactions involving antidepressants: focus on venlafaxine. J Clin Psychopharmacol 1996;19(suppl 2):S37–53.
   Google Scholar
• Levy RH, Mather GG. Metabolic enzymes and antiepileptic drug interactions. Adv Neurol 1998;76:49–55.
   PubMedGoogle Scholar
• Ghanem AA, Hazem M, Mandour RA. Drug and substance abuse in refractory epilepsy. Egypt J Neurol Psychiat Neurosurg 2008;45:387–394.
   Google Scholar
• Dudra-Jastrzebska M, Andres-Mach MM, Lucszczki JJ, Czuczwar SJ. Mood disorders in patients with epilepsy. Pharmacol Rep 2007;59:369–378.
   PubMed Web of Science ®Google Scholar
• Harden CL, Goldstein MA. Mood disorders in patients with epilepsy. Epidemiology and management. CNS Drugs 2002;16:291–302.
   PubMed Web of Science ®Google Scholar
• Garcia CS. Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations. Epilepsy Res Treat 2012;2012:809843. doi: 10.1155/2012/809843. Epub 2011 Dec 1.
   Google Scholar
• Mula M, Schmitz B, Sander JW. The pharmacological treatment of depression in adults with epilepsy. Expert Opin Pharmacother 2008;9:3159–3168.
   PubMed Web of Science ®Google Scholar
• Lambert NV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(suppl 10):S21–47.
   PubMed Web of Science ®Google Scholar
• Kalinowsky LB, Kennedy F. Observations I electroshock therapy applied to the problems of epilepsy. J Nerv Ment Dis 1943;98:56–67
   Google Scholar
• Keller CH, Bernsterin HJ. ECT as a treatment ffor neurologic illness. In: Coffey CE, ed. The clinical science of electroconvulsive therap. Washington, DC: American Psychiatric Press; 1993;183–210.
   Google Scholar
• Green AR. Changes in gamma aminobutyric acid biochemistry and seizure threshold. Ann N Y Acad Sci 1986;462:105–119.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Duchowny MS. Seizures after convulsive therapy: a retrospective case survey. Neurology 1983;33:921–925.
   PubMed Web of Science ®Google Scholar
• Hsiao JK, Messenheimer JA, Evans DL. ECT and neurological disorders. Convuls Ther 1987;3:121–136.
   PubMedGoogle Scholar
• Harden CL, Pulver MC, Ravdin LD, et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000;1:93–99.
   PubMed Web of Science ®Google Scholar
• Milby AH, Halpern CH, Baltuch GH. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 2008;5:75–85.
   PubMed Web of Science ®Google Scholar
• Bonaz B, Picq C, Sinniger V, et al. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 2013;25:208–221.
   PubMed Web of Science ®Google Scholar
• Koubeissi MZ, Kahriman E, Syed TU, et al. Low-frequency electrical stimulation of a fiber treact in temporal lobe epilepsy. Ann Neurol 2013;74:223–231.
   PubMed Web of Science ®Google Scholar
• Rashid S, Pho G, Czigler M, et al. Low frequency stimulation of ventral hippocampal commissures reduces seizures in a rat model of chronic temporal lobe epilepsy. Epilepsia 2012;53:147–156.
   PubMed Web of Science ®Google Scholar
• Hotzheimer PE, Mayberg HS. Deep brain stimulation for treatment-resistant depression. Am J Psychiatry 2010;167:1437–1444.
   PubMed Web of Science ®Google Scholar
• Gandy M, Sharpe L, Perry KN. Cognitive behavior therapy for depression in people with epilepsy: a systematic review. Epilepsia 2013;54:1725–34.
   PubMed Web of Science ®Google Scholar
• Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008;7:500–506.
   PubMed Web of Science ®Google Scholar
• Dahlin M, Mansson JE, Amark P. CSF levels of dopamine and serotonin, but not norepinephrine, metabolites are influenced by the ketogenic diet in children with epilepsy. Epilepsy Res 2012;99:132–138.
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Paskitti ME. The ketogenic diet may have mood-stabilizing properties. Med Hypotheses 2001;57:724–726.
   PubMed Web of Science ®Google Scholar
• Murphy P, Likhodii S, Nylen K, Burnham WM. The antidepressant properties of the ketogenic diet. Biol Psychiatry 2004;56:981–983.
   PubMed Web of Science ®Google Scholar
• Murphy P, Burnham WM. The ketogenic diet causes a reversible decrease in activity level in Long-Evans rats. Exp Neurol 2006;201:84–89.
   PubMed Web of Science ®Google Scholar
• Igelstrom KM, Heyward PM. The antidepressant drug fluoxetine inhibits prersistent sodium currents snd seizure-like events. Epilepsia 2012;101:174–181.
   Google Scholar
• Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160–162.
   PubMed Web of Science ®Google Scholar
• Ago J, Ishikawa T, Matsumoto N, et al. Mechanism of imipranime-induced seizures in amygdala-kindled rats. Epilepsy Res 2006;72:1–9.
   PubMed Web of Science ®Google Scholar
• Ago J, Ishikawa T, Matsumoto N, et al. Epileptiformic activity induced by antidepressants in amygdala0kindled rats. Eur J Pharmacol 2007;560:23–28.
   PubMed Web of Science ®Google Scholar
• Cardamone L, Salzberg MR, O’Brien TJ, Jones NC. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharm 2013;168:1531–1554.
   PubMed Web of Science ®Google Scholar
• Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010;329:959–964.
   PubMed Web of Science ®Google Scholar
• Russo E, Citraro R, Donato G, et al. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology 2013;69:25–36.
   PubMed Web of Science ®Google Scholar
• Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 2010;51:27–36.
   PubMed Web of Science ®Google Scholar
• Russo E, Citraro R, Donato G, et al. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology 2013;69:25–36.
   PubMed Web of Science ®Google Scholar
• Bengzon J, Kokaia Z, Elmer E, et al. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 1997;94:10432–10437.
   PubMed Web of Science ®Google Scholar
• Hattiangady B, Rao MS, Shetty AK. Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol Dis 2004;17:473–490.
   Google Scholar
• Hattiangady B, Shetty AK. Dereased neuronal differentiation of newly generated cells underlies reduced hippocampal neurogenesis in chronic temporal lobe epilepsy. Hippocampus 2010;20:97–112.
   PubMed Web of Science ®Google Scholar
• Boldrini M, Underwood MD, Hen Rm Rosoklija GB, et al. Antidepressans increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009;34:2376–2389.
   PubMed Web of Science ®Google Scholar
• Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104–9110.
   PubMed Web of Science ®Google Scholar
• Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805–809.
   PubMed Web of Science ®Google Scholar
• Miller BH, Schultz LE, Gulati A, et al. Genetic regulation of behavioral and neuronal response to fluoxetine. Neuropsychopharmacology 2008;33:1312–1322.
   PubMed Web of Science ®Google Scholar
• Jaako K, Zharkovsky T, Zharkovsky A. Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus. Brain Res 2009;1288:19–28.
   Google Scholar
• Jaako K, Aonurm-Helm A, kalda A, et al. Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus. Eur J Pharmacol 2011;666:61–71.
   PubMed Web of Science ®Google Scholar
• Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonine and epilepsy. J Neurochem 2007;100:857–873.
   PubMed Web of Science ®Google Scholar
• Lu KT, Gean PW. Endogenous serotonine inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine 1A receptor activation. Neuroscience 1998;86:729–737.
   PubMed Web of Science ®Google Scholar
• Olsen RW, DeLorey TM, Gordey M, Kang MH. GABA receptor function and epilepsy. Adv Neurol 1999;79:299–510.
   Google Scholar
• Krystal JH, Sanacora G, Blumber H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stablizing treatments. Mol Psychiatry 2002;7(suppl 1):s71–s80.
   PubMedGoogle Scholar
• Kanner AM. Epilepsy and mood disorders. Epilepsia 2007;48(suppl 9):20–22.
   PubMed Web of Science ®Google Scholar
• Cramer JA, Blum D, Reed M, et al. The influence of comorbid depression on quality of life for people with epilepdsy. Epilepsy Behav 2003;4:515–521.
   PubMed Web of Science ®Google Scholar
• Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007;75:192–196.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 2008;21:190–194.
   PubMed Web of Science ®Google Scholar